Table 3.
Prevalence of any HPV in placenta.
| HPV in placenta |
Total |
HPV DNA positive women at 1st trimester |
HPV negative women at 1st trimester |
|||
|---|---|---|---|---|---|---|
| n | % (95% CI) | n | % (95% CI) | n | % (95% CI) | |
| BRUSH | ||||||
| HPV positive | 18 | 14% (8–21) | 16 | 27% (16–40) | 2 | 3% (0.3–10) |
| HPV negative | 112 | 86% (79–92) | 44 | 73% (60–84) | 68 | 97% (90–99) |
| ß-globin neg | 0 | – | 0 | – | 0 | – |
| Total tested | 130 | 60 | 70 | |||
| Missinga | 37 | |||||
| BIOPSY | ||||||
| HPV positive | 6 | 5% (2–10) | 5 | 8% (3–18) | 1 | 2% (1–7) |
| HPV negative | 124 | 95% (90–98) | 55 | 92% (82–97) | 69 | 98% (93–99) |
| Total tested | 130 | 60 | 70 | |||
n=Number.
a
Missing results included pregnancy interruption, withdrawn, women who gave birth to another hospital and missing HPV DNA testing on placenta at birth.